Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0001567619-23-002400

Chief Business - Strategy Off acquired 12,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lin Patrick Chief Business - Strategy Off 2023-02-09 Grant or award +12,500 $0.80 $10,000 450,835 D
Loading xslF345X03/doc1.xml…